Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
disease | 0.300 | None | 1.000 | 24 | 0 | 1995 | 2011 | ||||||||
|
retinoic acid receptor alpha | 0.470 | 0.846 | 0.96 |
|
disease | 0.700 | None | 0.981 | 24 | 0 | 1990 | 2020 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
disease | 0.400 | None | 1.000 | 22 | 0 | 1990 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.500 | None | 1.000 | 21 | 0 | 2001 | 2019 | ||||||||
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
phenotype | 0.300 | None | 1.000 | 21 | 0 | 2001 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.600 | None | 1.000 | 21 | 0 | 1990 | 2019 | ||||||||
|
promyelocytic leukemia | 0.477 | 0.846 | 0.21 |
|
disease | 0.600 | None | 0.978 | 21 | 0 | 1990 | 2020 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
phenotype | 0.500 | None | 1.000 | 20 | 0 | 1991 | 2011 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.400 | None | 1.000 | 20 | 0 | 1980 | 2020 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.310 | None | 1.000 | 20 | 0 | 1980 | 2018 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.310 | None | 1.000 | 20 | 0 | 1980 | 2020 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.300 | None | 1.000 | 20 | 0 | 1980 | 2010 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.300 | None | 1.000 | 20 | 0 | 1980 | 2010 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
phenotype | 0.300 | None | 1.000 | 20 | 0 | 1980 | 2010 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.300 | None | 1.000 | 20 | 0 | 1980 | 2010 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
disease | 0.330 | None | 1.000 | 20 | 0 | 1980 | 2020 | ||||||||
|
nuclear receptor binding SET domain protein 1 | 0.505 | 0.769 | 1.00 |
|
disease | 0.700 | definitive | 0.987 | 20 | 0 | 2002 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.600 | None | 0.973 | 19 | 0 | 1994 | 2019 | ||||||||
|
superoxide dismutase 1 | 0.379 | 0.962 | 0.18 |
|
disease | 0.400 | None | 1.000 | 19 | 0 | 1989 | 2020 | ||||||||
|
frataxin | 0.510 | 0.654 | 0.34 |
|
disease | 0.900 | definitive | 0.997 | 18 | 0 | 1976 | 2020 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.400 | None | 1.000 | 18 | 0 | 1993 | 2020 | |||||||||
|
actin gamma 1 | 0.477 | 0.846 | 4.8E-03 |
|
disease | 0.330 | definitive | 1.000 | 18 | 0 | 2003 | 2018 | ||||||||
|
gap junction protein beta 3 | 0.621 | 0.462 | 2.2E-03 |
|
disease | 0.900 | strong | 0.967 | 17 | 0 | 1998 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
disease | 0.670 | definitive | 1.000 | 17 | 0 | 1998 | 2016 | ||||||||
|
kininogen 1 | 0.481 | 0.885 | 3.2E-10 |
|
phenotype | 0.560 | None | 0.958 | 17 | 0 | 1988 | 2019 |